The novel approach of the medication represents a exciting breakthrough in the management of type 2 diabetes. Distinct from existing drugs, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide065611.activablog.com/40965647/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment